YAP1 and nonpapillary renal cell carcinoma: ApoM overexpression inhibits proliferation, EMT, and metastasis by attenuating Hippo-YAP protein expression and YAP stability, as shown in Figure 4(Fig. 4), making ApoM a possible target for ccRCC treatment (Xu et al., 2023[159]).